Pediatric Ulcerative Colitis from Prevalence to Outcome

Journal Title: Journal of Clinical Gastroenterology and Treatment - Year 2017, Vol 3, Issue 2

Abstract

Purpose Pediatric Ulcerative Colitis (UC) is an Inflammatory Bowel Disease (IBD) that has potential morbidities, lifelong challenges and can leave both physical and psychosocial impacts. This study aimed to review the epidemiology, clinical presentations, and way of diagnosis, therapeutic approaches, complications and outcome of pediatric patients with UC. Methods A retrospective review of all patients diagnosed with UC in the pediatric department, Salmaniya medical complex, Bahrain, between 1984 and 2017 was conducted. Annual incidence and cumulative prevalence were calculated. Data about demographic and clinical characteristics; laboratory, radiological, endoscopic and histological investigations; medical therapy, number of exacerbations and hospital admissions, complications and outcomes were collected. Results Out of 108 pediatric patients diagnosed with IBD, 58 (53.7%) patients were found to have UC. The estimated annual incidence was 1/105/year (range from 0 to 6 patients). The prevalence was 16.3 patients per 100,000 pediatric populations. Thirty-three (56.9%) were females and 25 (43.1%) were males. Median age at the time of study was 22.9 years (range 5.8 to 41.8). The most common clinical presentations were bloody diarrhea and recurrent abdominal pain. Family history of IBD was found in five patients. Twenty-four (41.4%) patients had associated diseases. Ten (71.4%) patients had positive Anti-Neutrophil Cytoplasmic Antibodies (ANCA) test. Forty (81.6%) patients had pancolitis. The most frequent medications were prednisolone, mesalazine and azathioprine. Biological therapies were used in eight. Surgical intervention was required in nine. Four patients had colectomy. Two patients died at the age of 17 and 26 years. Both had an associated liver diseases and one died because of colon cancer. Conclusions The study showed a significant increase in incidence and prevalence of UC in Bahrain. Female predominance and a high association with autoimmune diseases might support the autoimmune theory as a cause for the disease. Despite medical therapy, significant morbidities and mortalities were reported.

Authors and Affiliations

Keywords

Related Articles

LRAT Promoter Hypermethylation as a Prognostic Marker for Colorectal Cancer Impairs Retinol Metabolism

Retinoids and its derivatives are known to regulate tumor progression. Our previous study in Colorectal Cancer (CRC) has shown that the expression of LRAT, a gene converts excess retinol into retinyl ester to balance ret...

Eradication of Helicobacter Pylori Infection: Past, Present and Future

This review is a comprehensive summary of different variants of anti-Helicobacter pylori therapy from past strategies to the current state of the art. Nowadays we see a progressive decreasing of eradication rate in many...

Pediatric Ulcerative Colitis from Prevalence to Outcome

Purpose Pediatric Ulcerative Colitis (UC) is an Inflammatory Bowel Disease (IBD) that has potential morbidities, lifelong challenges and can leave both physical and psychosocial impacts. This study aimed to review the ep...

Hepatotoxicity from Alpha-Methyldopa During Pregnancy: Two Case Reports

Abstract: A 29-year-old woman in her third pregnancy (at 22 weeks), with a history of arterial hypertension under treatment with enalapril, which medication was switched to α-methyldopa on gestation week 8. She then bega...

Unusual Mixed Presentations of Multiple Jejunal Diverticulae with Small Bowel Obstruction and Perforation - Case Report

Jejunal diverticulae are a rare phenomenon that is usually asymptomatic but can present with chronic abdominal pain or as an acute abdomen when complicated by intestinal diverticulitis, obstruction, haemorrhage or perfor...

Download PDF file
  • EP ID EP343813
  • DOI 10.23937/2469-584X/1510046
  • Views 122
  • Downloads 0

How To Cite

(2017). Pediatric Ulcerative Colitis from Prevalence to Outcome. Journal of Clinical Gastroenterology and Treatment, 3(2), 1-8. https://europub.co.uk/articles/-A-343813